Small Cap Biotechs Perk Up On Dealmaking
- All of our July 5 Picks are doing well but CCXI is up 88%.
- As we have written many times the XBI is the momentum indicator for small cap strength.
- All of these picks are volatile.
We are just back from a two-week vacation so we’ll be playing catch-up for a week or so. But as you can see in the chart below most of our small cap biotech picks are doing well. The Amgen $4B deal for ChemoCentryx has provided near term catalyst for these small cap biopharmas. ChemoCentryx has a recently approved drug for a rare immune system disorder.
And yesterday a report emend saying Pfizer is planning to buy Global Blood Therapeutics (GBT). for about $5B. We have recently turned bullish on more speculative small cap biotech stocks . With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.
We have written about small and mid cap biotech trades recently so check previous articles.
Small Cap Life Science Picks as of JY 5
| Initial | |||||||||
| COMPANY | Ticker | PRICE | Price | Mcap | W/C* | ANALYST | Perform | Perform | |
| 7/5/22 | 8/6 | $B | -000- | RATING | % MO. | % Week | |||
| ChemoCentryx | CCXI | 26.85 | 50.52 | 3.6 | 0.2 | 1.6 | 88.16 | 113.89 | Buyout $3.7B |
| CRSPR | CRSP | 70.6 | 81.4 | 6.31 | 2.15 | 2.2 | 15.3 | 8.53 | |
| Cryoport | CYRX | 33.97 | 39.4 | 1.95 | 0.62 | 1.6 | 15.98 | 5.91 | |
| Evolent Health | EVH | 32.16 | 35.74 | 3.27 | 0.09 | 1.4 | 11.13 | 5.15 | |
| Mirati | MRTX | 72 | 86.56 | 4.81 | 1.2 | 1.9 | 20.29 | 34.41 | |
| Moderna | MRNA | 155.54 | 186.84 | 73 | 6.9 | 2.5 | 20.12 | 13.86 | |
| Quidel/Ortho | QDEL | 100.41 | 92.2 | 6.71 | 1.6 | 2 | -8.18 | -9.64 | |
| Veracyte | VCYT | 23..41 | 27.9 | 2 | 0.175 | 2 | 19.18 | 5.92 | |
| FT NYSE Arca | FBT | 149.25 | 5.66 | 6.5 | |||||
| iShares | IBB | 131.44 | 7.03 | 5.93 | |||||
| SPDR S&P Bio | XBI | 92.3 | 13.96 | 13.77 | |||||
| SPDR Health | XLV | 131.45 | 1.95 | -0.72 | |||||
| iShares Russell 2 | IWM | 190.8 | 10.4 | 1.9 | |||||
More By This Author:
Broad Market Rallies Despite Currency Headwinds
Small Cap Biotech Stocks Are Trending Well
Small Cap Biotechs Regain Momentum
Comments
